5 Top Drug/Biotech Merger & Acquisition Targets for 2019

5 Top Drug/Biotech Merger & Acquisition Targets for 2019

Source: 
Yahoo/Zacks.com
snippet: 

Overall, the outlook for pharma/biotech M&A deal remains bullish for 2019 due to growing availability of capital for these firms and a lot of innovation happening in the sector.